China Universal Asset Management Co., Ltd. Acadia Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 35,281 shares of ACAD stock, worth $606,127. This represents 0.06% of its overall portfolio holdings.
Number of Shares
35,281
Previous 31,903
10.59%
Holding current value
$606,127
Previous $490,000
32.04%
% of portfolio
0.06%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$737 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$240 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$207 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$150 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$125 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.78B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...